Literature DB >> 25573746

Tissue specific dysregulated protein subnetworks in type 2 diabetic bladder urothelium and detrusor muscle.

Sara E Tomechko1, Guiming Liu2, Mingfang Tao3, Daniela Schlatzer1, C Thomas Powell3, Sanjay Gupta3, Mark R Chance1, Firouz Daneshgari3.   

Abstract

Diabetes mellitus is well known to cause bladder dysfunction; however, the molecular mechanisms governing this process and the effects on individual tissue elements within the bladder are poorly understood, particularly in type 2 diabetes. A shotgun proteomics approach was applied to identify proteins differentially expressed between type 2 diabetic (TallyHo) and control (SWR/J) mice in the bladder smooth muscle and urothelium, separately. We were able to identify 1760 nonredundant proteins from the detrusor smooth muscle and 3169 nonredundant proteins from urothelium. Pathway and network analysis of significantly dysregulated proteins was conducted to investigate the molecular processes associated with diabetes. This pinpointed ERK1/2 signaling as a key regulatory node in the diabetes-induced pathophysiology for both tissue types. The detrusor muscle samples showed diabetes-induced increased tissue remodeling-type events such as Actin Cytoskeleton Signaling and Signaling by Rho Family GTPases. The diabetic urothelium samples exhibited oxidative stress responses, as seen in the suppression of protein expression for key players in the NRF2-Mediated Oxidative Stress Response pathway. These results suggest that diabetes induced elevated inflammatory responses, oxidative stress, and tissue remodeling are involved in the development of tissue specific diabetic bladder dysfunctions. Validation of signaling dysregulation as a function of diabetes was performed using Western blotting. These data illustrated changes in ERK1/2 phosphorylation as a function of diabetes, with significant decreases in diabetes-associated phosphorylation in urothelium, but the opposite effect in detrusor muscle. These data highlight the importance of understanding tissue specific effects of disease process in understanding pathophysiology in complex disease and pave the way for future studies to better understand important molecular targets in reversing bladder dysfunction.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25573746      PMCID: PMC4349983          DOI: 10.1074/mcp.M114.041863

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  52 in total

Review 1.  Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells.

Authors:  K Kaibuchi; S Kuroda; M Amano
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Time dependent changes in diabetic cystopathy in rats include compensated and decompensated bladder function.

Authors:  Firouz Daneshgari; Guiming Liu; Peter B Imrey
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

Review 3.  Rho GTPases and signaling networks.

Authors:  L Van Aelst; C D'Souza-Schorey
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

4.  Genetic analysis of a new mouse model for non-insulin-dependent diabetes.

Authors:  J H Kim; S Sen; C S Avery; E Simpson; P Chandler; P M Nishina; G A Churchill; J K Naggert
Journal:  Genomics       Date:  2001-06-15       Impact factor: 5.736

Review 5.  The glutathione S-transferases: influence of polymorphism on cancer susceptibility.

Authors:  R C Strange; A A Fryer
Journal:  IARC Sci Publ       Date:  1999

Review 6.  Metabolism and functions of glutathione in brain.

Authors:  R Dringen
Journal:  Prog Neurobiol       Date:  2000-12       Impact factor: 11.685

7.  The function of intermediate filaments in cell shape and cytoskeletal integrity.

Authors:  R D Goldman; S Khuon; Y H Chou; P Opal; P M Steinert
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

8.  Molecular targets for diabetes mellitus-associated erectile dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; Moses T Tar; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

Review 9.  Diabetic bladder dysfunction: current translational knowledge.

Authors:  Firouz Daneshgari; Guiming Liu; Lori Birder; Ann T Hanna-Mitchell; Samuel Chacko
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

10.  Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006.

Authors:  Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 17.152

View more
  4 in total

Review 1.  Path of translational discovery of urological complications of obesity and diabetes.

Authors:  Firouz Daneshgari; Guiming Liu; Ann T Hanna-Mitchell
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-04

2.  Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator.

Authors:  Danica D Wiredja; Marzieh Ayati; Sahar Mazhar; Jaya Sangodkar; Sean Maxwell; Daniela Schlatzer; Goutham Narla; Mehmet Koyutürk; Mark R Chance
Journal:  Proteomics       Date:  2017-10-25       Impact factor: 3.984

3.  Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects.

Authors:  Muhammad Shahid; Minhyung Kim; Austin Yeon; Peng Jin; Woong-Ki Kim; Sungyong You; Jayoung Kim
Journal:  Int Neurourol J       Date:  2020-03-31       Impact factor: 2.835

4.  IR-61 Improves Voiding Function via Mitochondrial Protection in Diabetic Rats.

Authors:  Jianwu Wang; Linyong Dai; Xiaofeng Yue; Chongxing Shen; Tong Li; Lei Long; Yi Zhi; Yawei Wang; Gufang Shen; Chunmeng Shi; Yunsheng Liu; Qiang Fang; Weibing Li
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.